• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗保健中的技术评估:实现生物医学工程目标的一种手段。

Technology assessment in healthcare: a means for pursuing the goals of biomedical engineering.

作者信息

Goodman C S

机构信息

Clifford Goodman & Associates, Washington, DC 20008.

出版信息

Med Biol Eng Comput. 1993 Jan;31(1):HTA3-10. doi: 10.1007/BF02446885.

DOI:10.1007/BF02446885
PMID:8326756
Abstract

The goals of biomedical engineering include the improvement of health and life quality of mankind. However, the contribution of biomedical engineering to those worthy ends must be more clearly related. Biomedical engineers should become more active in demonstrating to policymakers and other parties in healthcare the value of the contributions of healthcare technology. Technology assessment (TA) is a form of investigation designed to identify and evaluate the implications of technologies so as to inform policymaking. Among the important trends in TA that should be of special interest to biomedical engineers are the increasingly higher methodological standards for accepting evidence from clinical investigations, and the use of quality-of-life measures for determining how technologies affect people's lives.

摘要

生物医学工程的目标包括改善人类的健康和生活质量。然而,生物医学工程对这些有价值目标的贡献必须更加明确地联系起来。生物医学工程师应更加积极地向政策制定者和医疗保健领域的其他各方展示医疗技术贡献的价值。技术评估(TA)是一种旨在识别和评估技术影响以便为政策制定提供信息的调查形式。在技术评估中,生物医学工程师应特别关注的重要趋势包括接受临床研究证据的方法标准越来越高,以及使用生活质量衡量标准来确定技术如何影响人们的生活。

相似文献

1
Technology assessment in healthcare: a means for pursuing the goals of biomedical engineering.医疗保健中的技术评估:实现生物医学工程目标的一种手段。
Med Biol Eng Comput. 1993 Jan;31(1):HTA3-10. doi: 10.1007/BF02446885.
2
Healthcare technology, economics, and policy: an evolving balance.医疗保健技术、经济学与政策:一种不断演变的平衡。
IEEE Eng Med Biol Mag. 2003 Jan-Feb;22(1):16-9. doi: 10.1109/memb.2003.1191444.
3
Technology assessment and biomedical engineering education.技术评估与生物医学工程教育。
Med Biol Eng Comput. 1993 Jan;31(1):HTA33-6. doi: 10.1007/BF02446891.
4
Health Technology Assessment and Biomedical Engineering: Global trends, gaps and opportunities.卫生技术评估与生物医学工程:全球趋势、差距与机遇。
Med Eng Phys. 2019 Oct;72:19-26. doi: 10.1016/j.medengphy.2019.08.008.
5
Assessment of medical technology: the role of engineers.医疗技术评估:工程师的作用。
Med Biol Eng Comput. 1993 Jan;31(1):HTA11-5. doi: 10.1007/BF02446886.
6
Do biomedical engineers have a role in healthcare technology assessment?生物医学工程师在医疗技术评估中是否发挥作用?
Med Biol Eng Comput. 1993 Jan;31(1):HTA1-2. doi: 10.1007/BF02446884.
7
Who, what, where, when, why and how: technology assessment in a hospital setting.何人、何事、何地、何时、为何及如何:医院环境中的技术评估
Med Biol Eng Comput. 1993 Jan;31(1):HTA25-7. doi: 10.1007/BF02446889.
8
HEALTH TECHNOLOGY ASSESSMENT METHODS GUIDELINES FOR MEDICAL DEVICES: HOW CAN WE ADDRESS THE GAPS? THE INTERNATIONAL FEDERATION OF MEDICAL AND BIOLOGICAL ENGINEERING PERSPECTIVE.医疗器械卫生技术评估方法指南:如何弥补差距?国际医学和生物学工程联合会的观点。
Int J Technol Assess Health Care. 2018 Jan;34(3):276-289. doi: 10.1017/S0266462318000314. Epub 2018 Jun 18.
9
Commercialising biomedical technology.生物医学技术商业化。
Australas Phys Eng Sci Med. 1989 Jun;12(2):107-10.
10
Outcomes measurement: health state preferences and economic evaluation.结果测量:健康状态偏好与经济评估。
Assist Technol. 1996;8(2):94-102. doi: 10.1080/10400435.1996.10132279.

本文引用的文献

1
What ever happened to biliary lithotripsy.胆道碎石术后来怎么样了?
J Lithotr Stone Dis. 1991 Apr;3(2):121-4.
2
The role of evidence in the consensus process. Results from a Canadian consensus exercise.证据在共识达成过程中的作用。一项加拿大共识达成活动的结果。
JAMA. 1988 May 27;259(20):3001-5.
3
The quality of medical evidence: implications for quality of care.医学证据的质量:对医疗质量的影响。
Health Aff (Millwood). 1988 Spring;7(1):19-32. doi: 10.1377/hlthaff.7.1.19.
4
Multidimensionality of health status in an elderly population. Construct validity of a measurement battery.老年人群健康状况的多维性。一套测量工具的结构效度。
Med Care. 1989 Mar;27(3 Suppl):S168-77. doi: 10.1097/00005650-198903001-00014.
5
Rules of evidence and clinical recommendations on the use of antithrombotic agents.抗血栓药物使用的证据规则和临床建议。
Chest. 1989 Feb;95(2 Suppl):2S-4S.
6
Generic and disease-specific measures in assessing health status and quality of life.评估健康状况和生活质量的通用及疾病特异性指标。
Med Care. 1989 Mar;27(3 Suppl):S217-32. doi: 10.1097/00005650-198903001-00018.
7
Quality of life, health status, and clinical research.生活质量、健康状况与临床研究。
Med Care. 1989 Mar;27(3 Suppl):S148-56. doi: 10.1097/00005650-198903001-00012.
8
Utilities and quality-adjusted life years.效用与质量调整生命年。
Int J Technol Assess Health Care. 1989;5(4):559-75. doi: 10.1017/s0266462300008461.
9
Application of health status assessment measures in policy research.健康状况评估措施在政策研究中的应用。
Med Care. 1989 Mar;27(3 Suppl):S12-26. doi: 10.1097/00005650-198903001-00002.
10
Quality-adjusted life years, utility theory, and healthy-years equivalents.质量调整生命年、效用理论与健康年当量。
Med Decis Making. 1989 Apr-Jun;9(2):142-9. doi: 10.1177/0272989X8900900209.